A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus
Open Access
- 28 February 2011
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 64 (6), e99-e104
- https://doi.org/10.1016/j.jaad.2010.06.011
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitisJournal of Allergy and Clinical Immunology, 2009
- The Vulvar DermatosesThe Journal of Sexual Medicine, 2008
- Pimecrolimus 1% cream in the treatment of vulvar lichen sclerosus in postmenopausal womenInternational Journal of Dermatology, 2007
- Pimecrolimus Cream 1% in the Treatment of Lichen SclerosusGynecologic and Obstetric Investigation, 2006
- Pimecrolimus 1% cream for anogenital lichen sclerosus in childhoodBMC Dermatology, 2004
- Pimecrolimus for the treatment of vulvar lichen sclerosus in a premenarchal girlJournal of Pediatric and Adolescent Gynecology, 2004
- Guidelines for the management of lichen sclerosusBritish Journal of Dermatology, 2002
- The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled studyBritish Journal of Dermatology, 2001
- Clobetasol dipropionate 0.05% versus testosterone propionate 2% topical application for severe vulvar lichen sclerosusAmerican Journal of Obstetrics and Gynecology, 1998
- Topical testosterone in the treatment of vulvar lichen sclerosusInternational Journal of Gynecology & Obstetrics, 1994